Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joanna Tajer
Observed name:
J. Tajer
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institutions:
Centrum Onkologii,
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0000-0002-8962-1887
Observed ORCID:
0000-0002-8962-1887
OpenAlex ID:
A5082219558
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study
2016
·
Claudio Agostinelli
, Andrea Gallamini
, et al.
·
The Lancet Haematology
·
80
Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study
2017
·
Colette Zwarthoed
, Tarec Cristoffer El-Galaly
, et al.
·
Journal of Nuclear Medicine
·
34
PDF
The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin’s lymphoma patients—the Polish Lymphoma Research Group (PLRG) Observational Study
2017
·
J.M. Zaucha
, B. Małkowski
, et al.
·
Annals of Oncology
·
20
Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma
2011
·
Maria Kowalska
, Joanna Tajer
, et al.
·
Medical Oncology
·
18
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up
2022
·
Joanna Romejko-Jarosinska
, Beata Ostrowska
, et al.
·
Scientific Reports
·
11
PDF
Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma
2012
·
Maria Kowalska
, Joanna Tajer
, et al.
·
Tumor Biology
·
11
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine ( R‐MIV ) in patients with primary CNS lymphoma including recent COVID ‐19 pandemic experience
2023
·
Beata Ostrowska
, Katarzyna Domanska‐Czyz
, et al.
·
British Journal of Haematology
·
8
PDF
CHOP-21 for unfavorable Hodgkin’s lymphoma. An exploratory study
2009
·
Jan Walewski
, Elżbieta Lampka
, et al.
·
Medical Oncology
·
6
The Prognostic Role of Interim PET after First Chemotherapy Cycle and PET Sequential Evaluation of Response to ABVD in Hodgkin Lymphoma Patients - the Polish Lymphoma Research Group (PLRG) Observational Study
2015
·
Jan M Zaucha
, Bogdan Malkowski
, et al.
·
Blood
·
5
Transformation in lymphomas--morphological, immunophenotypic and molecular features.
2006
·
Monika Prochorec-Sobieszek
, Mirosław Majewski
, et al.
·
PubMed
·
4
Peripheral Blood Cells from Patients with Hodgkin’s and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs
2021
·
Ewa Paszkiewicz-Kozik
, Agnieszka Paziewska
, et al.
·
BioMed Research International
·
2
PDF
Subcutaneous Compared to Intravenous Administration of Rituximab Plus CHOP in Patients with Diffuse Large B-Cell Lymphoma — a Study By the Polish Lymphoma Research Group
2017
·
Ewa Paszkiewicz‐Kozik
, Monika Długosz‐Danecka
, et al.
·
Blood
·
2
CHOP Chemotherapy for Unfavorable or Advanced Hodgkin’s Lymphoma. A Pilot Study.
2004
·
Jan Walewski
, Elzbieta Lampka
, et al.
·
Blood
·
2
The long-term efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in the treatment of primary central nervous system lymphoma: A real-world report from the Polish Lymphoma Research Group
2026
·
Beata Ostrowska
, Katarzyna Domanska-Czyz
, et al.
·
European Journal of Cancer
·
1
PDF
614 | Long Term Follow‐up of Patients With Mantle Cell Lymphoma, Who Underwent High‐dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in First Remission
2025
·
J. Romejko‐Jarosinska
, E. Paszkiewicz‐Kozik
, et al.
·
Hematological Oncology
·
1
PDF
Unexpected cutaneous toxicity of IGEV regimen in patients with Hodgkin lymphoma.
2011
·
E. Paszkiewicz-Kozik
, J. Romejko-Jarosinska
, et al.
·
Journal of Clinical Oncology
·
1
863 | Radiotherapy in Pregnant Patients With Hodgkin’s Lymphoma: Clinical Outcomes and Dosimetric Assessment
2025
·
E. Wojciechowska‐Lampka
, M. Rosińska
, et al.
·
Hematological Oncology
PDF
355 | Efficacy and Safety of the Eva Chemotherapy Regimen in Pregnant Patients With Hodgkin’s Lymphoma: a Long‐term Outcome Analysis
2025
·
E. Wojciechowska‐Lampka
, M. Rosińska
, et al.
·
Hematological Oncology
PDF
Autologous Hematopoietic Cell Transplantation for Primary Central Nervous System Lymphoma (pcnsl). Real‐world Report of Polish Lymphoma Research Group.
2023
·
B. Ostrowska
, K. Domanska‐Czyz
, et al.
·
Hematological Oncology
PDF
Clinicopathological characteristics and outcome of plasmablastic lymphoma patients: A single-center retrospective analysis.
2020
·
Anna P Dabrowska-Iwanicka
, Joanna Romejko-Jarosinska
, et al.
·
Journal of Clinical Oncology
Patients with classical H odgkin lymphoma ( CHL ) and treatment failure despite a negative iPET have poor outcomes as patients with positive iPET and treatment escalation
2017
·
J.M. Zaucha
, W. Khair
, et al.
·
Hematological Oncology
PDF
Only focal bone marrow FDG uptake in baseline FDG Pet scan has a diagnostic and prognostic impact in Hodgkin Lymphoma
2016
·
C. Zwarthoed
, Tarec Christoffer El‐Galaly
, et al.
·
VBN Forskningsportal (Aalborg Universitet)
PDF
Zastosowanie wczesnego badania PET po 1 cyklu ABVD u chorych na chłoniaka Hodgkina (HL) leczonych schematem ABVD – wieloośrodkowe badanie obserwacyjne Polskiej Grupy Badawczej Chłoniaków (PLRG)
2013
·
J.M. Zaucha
, B. Małkowski
, et al.
·
Acta Haematologica Polonica
Stężenia VEGF i bFGF w surowicy krwi chorych na chłoniaka Hodgkina
2007
·
Magdalena Kowalska
, Joanna Kamińska
, et al.
·
Nowotwory Journal of Oncology
Stężenia cytokin prozapalnych i inhibitorowych w surowicy krwi chorych na chłoniaka Hodgkina
2007
·
Magdalena Kowalska
, Joanna Kamińska
, et al.
·
Nowotwory Journal of Oncology
Show more works
View as search
Works count:
38
Citation count:
206
H-index:
7
I10-index:
6
Year
Topic
Type